賽微電子(300456.SZ):擬使用不超1億美元開展外匯衍生品交易業務
格隆匯 3 月 16日丨賽微電子(300456.SZ)公佈,公司於2021年3月16日召開的第四屆董事會第十次會議、第四屆監事會第九次會議審議通過了《關於開展外匯衍生品交易業務的議案》,同意公司及子公司根據經營發展的需要,使用不超過1億美元(含等值其他幣種)開展外匯衍生品交易業務,上述交易額度自董事會及監事會審議通過之日起24個月內可以滾動使用,單筆交易的期限不超過12個月。董事會同意授權董事長行使該項投資決策權並簽署或授權相關子公司負責人簽署相關合同與文件,公司財務負責人負責外匯衍生品交易業務的具體操作和管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.